loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Looking for Pharmaceutical Excipients offered by Nomisma Healthcare? Find Poly-DL-Lactic-co-Glycolic Acid / PLGA-PEG to address your drug delivery challenges on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 Injectable / Parenteral (1)

02 Tablet (2)

filter

01 India (3)

Close
4

PLGA

LM Application #LearnMore

Applications:

PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Ingredient(s): Poly DL Lactide co Glycolide

Dosage Form: Injectable / Parenteral, Tablet

Category: Controlled & Modified Release, Parenteral

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY